Results 261 to 270 of about 119,936 (354)

Exploring the Pleiotropic Cardioprotective Effects of GLP-1 Receptor Agonists in Preventing Anthracycline-Induced Cardiotoxicity: A Theoretical Proposal for Future Research. [PDF]

Medicines (Basel)
Repp ML, Chinyere IR, Teran S, Bast J, Kondapalli L.   +4 more
europepmc   +1 more source

Cardiac digital twins: Modelling the arrhythmic substrate of chemotherapy

The Journal of Physiology, EarlyView.
Radomir Chabiniok, Vlad G. Zaha
wiley   +1 more source

Clonal hematopoiesis in patients with cancer and cancer survivors: From clonal burden to cardiovascular diseases

Cancer, Volume 132, Issue 10, 15 May 2026.
ABSTRACT Over the past decade, clonal hematopoiesis (CH) has gained substantial attention as a prevalent, age‐associated phenomenon with major implications for hematologic malignancy, cardiovascular disease, and mortality. CH arises from the clonal expansion of hematopoietic stem cells and progenitor cells harboring somatic mutations, most commonly in ...
Christian H. Nenninger, Keith Anderson, Jenaro Espitia‐Corredor, Brittany Echevarria, Vertica Agnihotri, Zhao Wang, Scott R. Goldsmith, June‐Wha Rhee   +7 more
wiley   +1 more source

Correction to "MO Oxygen Therapy Prevents Doxorubicin-Induced Cardiotoxicity". [PDF]

Cardiol Res Pract
europepmc   +1 more source

Incidence and Predictors of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients at a Tertiary Academic Hospital in Indonesia: A Retrospective Cohort Study. [PDF]

Hosp Pharm
Fitrianti AE, Astuti A, Reyaan IBM, Hendrayana T, Rahmah SA, Anggadiredja K, Zazuli Z.   +6 more
europepmc   +1 more source

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

Pediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya, Veronica Moroz, Juliet Hale, Vesna Pavasovic, Rachel Hobson, Patricia Sartori, Daniel Saunders, Mark Powis, Gordan M. Vujanic, Stephen Baker, Kathy Pritchard‐Jones   +10 more
wiley   +1 more source

Pharmacogenomic predictors of anthracycline-induced cardiotoxicity in breast cancer patients: a systematic review and meta-analysis. [PDF]

Cardiooncology
Bulusu VM, Shah B, Sawant S, Choudhary A, Das S, Jain S, Mallayasamy SR, Udupa KS, Arya N, Singh J, Rao M, Kanwar RK, Kumar A, Munisamy M.   +13 more
europepmc   +1 more source

BLOC: Buildable and Linkable Organ on a Chip

Advanced Materials Technologies, Volume 11, Issue 9, 6 May 2026.
We developed a “Buildable and Linkable Organ on a Chip” (BLOC) that can construct diverse microphysiological systems (MPSs). The BLOC is standardized to the same size and has one of the functions of “Culture,” “Control,” or “Analysis.” Users can freely configure various MPSs, including developing perfusion, cytotoxicity analysis, and biochemical ...
Yusuke Kimura, Hiroki Hamaguchi, Kotaro Oyama, Tomoko G. Oyama, Atsushi Kimura, Yasuhiro Ohshima, Noriko S. Ishioka, Mitsumasa Taguchi   +7 more
wiley   +1 more source

Charting the Current Landscape and Future Prospects of Cancer Therapy-Related Cardiovascular Toxicity in Cancer Survivors: From Bench to Bedside. [PDF]

Drug Des Devel Ther
Tao S, Yu L, Zhang L, Li J, Wu J, Tan Y.
europepmc   +1 more source